大型学术医学中心实施原发HPV检测在宫颈癌筛查中的经验与影响
本文回顾宫颈癌筛查从巴氏涂片到原发HPV检测的演变,指出美国癌症协会已将原发HPV检测推荐为首选方法,美国预防服务工作组预计也将予以认可。作者还介绍了启动原发HPV检测的机构经验,重点讨论其对细胞病理实验室工作流程和标本量的影响,以及HPV阳性病例的分流策略。
要点
- 美国癌症协会推荐原发HPV检测作为宫颈癌筛查首选方法。
- 向原发HPV筛查过渡需规划HPV阳性病例的分流策略。
- 机构经验显示原发HPV检测影响细胞病理实验室工作流程与标本量。
核心结论
- 宫颈癌筛查指南已从以细胞学为主转向基于HPV的检测,原发HPV检测被推荐为首选方法。
研究设计与样本
- 本文为综述及单机构经验总结,追溯宫颈癌筛查从巴氏涂片到现行指南推荐的演变。
主要发现
- 美国癌症协会推荐原发HPV检测作为首选筛查方法,美国预防服务工作组预计将类似认可。
- 作者机构启动原发HPV检测的经验显示其对细胞病理实验室工作流程和标本量产生影响。
关键数值与推荐
- 美国癌症协会推荐原发HPV检测为宫颈癌筛查首选方法。
临床怎么用
- 向原发HPV筛查过渡时需建立HPV阳性病例的分流策略。
- 细胞病理实验室需评估原发HPV检测对工作流程和标本量的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recognition of high-risk human papillomavirus (HPV) as the etiologic agent in nearly all cervical cancers has fundamentally reshaped screening strategies, driving the development and adoption of highly sensitive molecular HPV assays. Over the past several decades, cervical cancer screening guidelines have shifted from primarily cytology-based approaches toward HPV-based modalities, with primary HPV testing now recommended as the preferred method by the American Cancer Society and anticipated to be similarly endorsed by the United States Preventive Services Task Force. This article traces the evolution of cervical cancer screening, from the original Papanicolaou test to current guideline recommendations, and discusses the logistical requirements for transitioning to a primary HPV screening system, including triage strategies for HPV-positive cases. The authors additionally present an institutional experience of initiating primary HPV testing, highlighting its impact on cytopathology laboratory workflow and specimen volumes.
引用
- Yoda RA, Huang EC. Implementation and impact of primary HPV testing in cervical cancer screening: Historical perspectives and institutional experience at a large academic medical center. Cancer Cytopathol. 2026. PMID: 42482480. doi:10.1002/cncy.70129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。